English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment Journal article
Yang, Zhenyun, Wang, Xin, Fu, Yizhen, Wu, Weijie, Hu, Zili, Lin, Qingyang, Peng, Wei, Pan, Yangxun, Wang, Juncheng, Chen, Jinbin, Hu, Dandan, Zhou, Zhongguo, Xu, Li, Zhang, Yaojun, Hou, Jiajie, Chen, Minshan. YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment[J]. Molecular Cancer, 2024, 23(1), 186.
Authors:  Yang, Zhenyun;  Wang, Xin;  Fu, Yizhen;  Wu, Weijie;  Hu, Zili; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:27.7/31.3 | Submit date：2024/10/10
ER translocon inhibitor ipomoeassin F inhibits triple-negative breast cancer growth via blocking ER molecular chaperones Journal article
Shishi Tao, Eun Ju Yang, Guanghui Zong, Pui Kei Mou, Guowen Ren, Yue Pu, Liang Chen, Ho Jeong Kwon, Jianhong Zhou, Zhijian Hu, Arman Khosravi, Qingyang Zhang, Yuchun Du, Wei Q. Shi, Joong Sup Shim. ER translocon inhibitor ipomoeassin F inhibits triple-negative breast cancer growth via blocking ER molecular chaperones[J]. Int J Biol Sci, 2023, 19(13), 4020-4035.
Authors:  Shishi Tao;  Eun Ju Yang;  Guanghui Zong;  Pui Kei Mou;  Guowen Ren; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:8.2/8.3 | Submit date：2023/08/30
Ipomoeassin f  Er Stress  Er Translocon  Tnbc  Pdia6  Pdia4